Exact Sciences (EXAS) Earnings Call Transcripts

Price: $42.26
Market Cap: $7.85B
Avg Volume: 2.33M
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 1.139
52W Range: $39.97-72.83
Website: Exact Sciences
Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-19 $-0.29 $-0.06
Read Transcript Q3 2024 2024-11-05 $-0.20 $-0.21
Read Transcript Q2 2024 2024-07-31 $-0.37 $-0.09
Read Transcript Q1 2024 2024-05-08 $-0.47 $-0.50
Read Transcript Q4 2023 2024-02-21 $-0.53 $-0.27
Read Transcript Q3 2023 2023-11-01 $-0.48 $0.00
Read Transcript Q2 2023 2023-08-01 $-0.50 $-0.45
Read Transcript Q1 2023 2023-05-09 $-0.79 $-0.42
Read Transcript Q4 2022 2023-02-21 $-0.90 $-0.72
Read Transcript Q3 2022 2022-11-03 $-1.10 $-0.84
Read Transcript Q2 2022 2022-08-02 $-1.07 $-0.94
Read Transcript Q1 2022 2022-04-26 $-1.12 $-1.04
Read Transcript Q4 2021 2022-02-22 $-0.91 $-1.28
Read Transcript Q3 2021 2021-11-02 $-0.89 $-0.97
Read Transcript Q2 2021 2021-07-28 $-0.72 $-1.03
Read Transcript Q1 2021 2021-05-04 $-1.04 $-0.18
Read Transcript Q4 2020 2021-02-16 $-0.19 $-0.09
Read Transcript Q3 2020 2020-10-30 N/A N/A
Read Transcript Q2 2020 2020-07-30 $-0.62 $-0.58
Read Transcript Q1 2020 2020-05-06 $-0.57 $-0.60
Read Transcript Q4 2019 2020-02-12 N/A N/A
Read Transcript Q3 2019 2019-10-29 $-0.41 $-0.31
Read Transcript Q2 2019 2019-07-29 $-0.56 $-0.30
Read Transcript Q1 2019 2019-04-30 $-0.64 $-0.66
Read Transcript Q4 2018 2019-02-21 $-0.50 $-0.44
Read Transcript Q3 2018 2018-10-31 N/A N/A
Read Transcript Q2 2018 2018-08-01 $-0.33 $-0.30
Read Transcript Q1 2018 2018-04-26 $-0.39 $-0.33
Read Transcript Q4 2017 2018-02-22 $-0.27 $-0.18
Read Transcript Q3 2017 2017-10-30 $-0.30 $-0.23
Read Transcript Q2 2017 2017-07-25 $-0.37 $-0.27
Read Transcript Q1 2017 2017-04-27 $-0.41 $-0.32
Read Transcript Q4 2016 2017-02-21 $-0.39 $-0.34
Read Transcript Q3 2016 2016-10-26 $-0.43 $-0.36
Read Transcript Q2 2016 2016-07-26 $-0.55 $-0.46
Read Transcript Q1 2016 2016-05-03 $-0.54 $-0.49

Related Metrics

Explore detailed financial metrics and analysis for EXAS.